ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation.

Cancer Medicine
Jianjun TangHongyan Zhu

Abstract

Recent studies highlight the regulatory role of arachidonate lipoxygenase5 (Alox5) and its metabolite 5-hydroxyeicosatetraenoic acid (5-HETE) in cancer tumorigenesis and progression. In this study, we analyzed the expression, biological function and the downstream signaling of Alox5 in gastric cancer. Alox5 protein levels were measured using IHC and ELISA. Growth, migration and survival assays were performed. Phosphorylation of molecules involved in growth and survival signaling were analyzed by WB. Analysis of variance and t-test were used for statistic analysis. Alox5 and 5-HETE levels were upregulated in gastric cancer patients. ALOX5 overexpression or 5-HETE addition activates gastric cancer cells and reduces chemotherapy's efficacy. In contrast, ALOX5 inhibition via genetic and pharmacological approaches suppresses gastric cancer cells and enhances chemotherapy's efficacy. In addition, Alox5 inhibition led to suppression of ERK-mediated signaling pathways whereas ALOX5-5-HETE activates ERK-mediated signaling in gastric cancer cells. Our work demonstrates the critical role of ALOX5-5-HETE in gastric cancer and provides pre-clinical evidence to initialize clinical trial using zileuton in combination with chemotherapy for tre...Continue Reading

References

Aug 6, 1998·Gynecologic and Obstetric Investigation·A PrzylipiakT Rabe
Jul 16, 1999·Biochemical and Biophysical Research Communications·X Z DingT E Adrian
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaoxin ChenChung S Yang
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ning LiXiaoxin Chen
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laleh G MelstromThomas A Adrian
Jan 19, 2012·Journal of Cellular Biochemistry·Nicolas T KummerJan Geliebter
Dec 9, 2014·Oncology Reports·Guo-Xiong ZhouHong Zhang
Dec 30, 2014·The Journal of Biological Chemistry·Sivalokanathan SarveswaranJagadananda Ghosh
Jan 17, 2015·World Journal of Gastroenterology : WJG·Shuhei KomatsuEigo Otsuji
Mar 2, 2016·Nature Reviews. Clinical Oncology·Florian Lordick, Yelena Y Janjigian
Apr 6, 2016·Acta Informatica Medica : AIM : Journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva Za Medicinsku Informatiku BiH·Naim MorinaGunay Halac
Feb 16, 2018·Cancer Management and Research·Robert SitarzWojciech P Polkowski
Jun 13, 2018·Critical Reviews in Oncology/hematology·Neha MerchantGanji Purnachandra Nagaraju
Oct 12, 2018·Current Opinion in Gastroenterology·David H Ilson
Sep 6, 2019·Cancer Metastasis Reviews·Alessio BiagioniLaura Papucci
Nov 2, 2019·Nanomedicine : Nanotechnology, Biology, and Medicine·Petra GenerSimo Schwartz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.